Neil Conlon is a PhD student and his project is investigating the ways in which breast cancer cells respond and adapt to current treatments. Neil recently produced a slidedeck (and an animated video) to illustrate his research for the 2016 DCU Tell It Straight competition. This competition challenged PhD students to communicate their research to a general audience through either a presentation or a video. This slidedeck outlines the main aims of Neil's PhD to investigate drug resistance in breast cancer and describes what his group are doing in the lab to achieve these aims

1. Blocking the roads to
resistance in breast
cancer
Neil Conlon

2. Breast cancer is the 2nd most common cancer in women

4. One in ten women diagnosed every year…

5. Breast cancer is more than one disease
HER2-positive
Hormone receptor
positive
Triple
Negative

6. HER2-positive
(~20%)
Aggressive
Poorer
prognosis
Other breast cancers
400 cases/
year

7. Cell
HER2

8. Cell Surface
Cell Growth
HER2

9. Cell
Death
,000’s have benefited from HER2-targeted drugs

10. Drug
Resistanc
Cell
Death

11. My Research

13. Look for druggable
weaknesses

14. Resistance is futile!

17. Thanks for
listening!